Piramal Pharma Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Total Qtr Revenue cr | 2,797.83 | ||||
| Other Income Qtr Cr | 46.06 | ||||
| Operating Revenues Qtr | 2,751.77 | ||||
Loading chart... | |||||
Operating Expenses Qtr | 2,291.26 | ||||
Operating Profit Qtr | 460.51 | ||||
EBITDA Qtr Cr | 330.80 | ||||
Depreciation Qtr | 218.38 | ||||
Net Profit Qtr | -8.82 | ||||
Basic EPS Qtr | -0.07 | ||||